Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19 (PROLUN)

U

University Hospital, Akershus

Status

Unknown

Conditions

Covid19
Lung Function Decreased

Treatments

Other: No interventions

Study type

Observational

Funder types

Other

Identifiers

NCT04535154
PROLUN

Details and patient eligibility

About

A multicenter prospective cohort study performed at 6 major teaching hospitals in Southern Norway to study patient reported outcomes, lung function and pulmonary CT in patients at 3 and 12 months after hospitalization for coronavirus disease 2019 (COVID-19).

Full description

This cohort study aim to describe the Natural course of COVID-19 disease in an consecutive and unselected cohort of Norwegians that have been hospitalized. In addition to the primary and secondary outcomes related to PROMS, lung function and pulmonary CT, the study also have several substudies: Cardiology: The study includes echocardiography, 24-h electrocardiography and cardiopulmonary exercise test. ENT: The study includes CT of head sinuses and patient-reported sleep disturbances and nose symptoms in a subgroup of patients. Laboratory: Analyses of common markers of inflammation and cardiac biomarkers.

Enrollment

264 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Discharged before June 1 2020 after hospitalization at participating hospital for COVID-19

Exclusion criteria

  • Age < 18 years
  • Dementia
  • Living outside hospital catchment area
  • Participation in WHO COVID-19 clinical trial

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems